Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study


NAXOS aimed to compare the safety, effectiveness and mortality of apixaban with vitamin K antagonists, rivaroxaban and dabigatran, in oral anticoagulant-naïve patients with nonvalvular AF.

Van Ganse E, Danchin N, Mahé I, et al. Stroke 2020;51:2066–75.